Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor - PubMed (original) (raw)
Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor
Y Kawakami et al. Proc Natl Acad Sci U S A. 1994.
Abstract
By cDNA expression cloning we have isolated a gene encoding a shared human melanoma antigen recognized by HLA-A2 restricted autologous and allogenic tumor-infiltrating lymphocytes (TILs) from patients with metastatic melanoma. By using both transient and stable expression systems, transfection of this gene into non-antigen-expressing HLA-A2+ cell lines resulted in recognition by the antigen-specific TILs. The sequence of this cDNA revealed a previously undescribed putative transmembrane protein whose expression was restricted to melanoma and melanocyte cell lines and human retina but no other fresh or cultured normal tissues tested or other tumor histologies. Thus, we have identified a gene encoding a melanocyte lineage-specific protein (MART-1; melanoma antigen recognized by T cells 1) that is a widely shared melanoma antigen recognized by the T lymphocytes of patients with established malignancy. Identification of this gene opens possibilities for the development of immunotherapies for patients with melanoma.
Similar articles
- Identification of a human melanoma antigen recognized by tumor-infiltrating lymphocytes associated with in vivo tumor rejection.
Kawakami Y, Eliyahu S, Delgado CH, Robbins PF, Sakaguchi K, Appella E, Yannelli JR, Adema GJ, Miki T, Rosenberg SA. Kawakami Y, et al. Proc Natl Acad Sci U S A. 1994 Jul 5;91(14):6458-62. doi: 10.1073/pnas.91.14.6458. Proc Natl Acad Sci U S A. 1994. PMID: 8022805 Free PMC article. - Use of an in vitro immunoselected tumor line to identify shared melanoma antigens recognized by HLA-A*0201-restricted T cells.
Harada M, Li YF, El-Gamil M, Rosenberg SA, Robbins PF. Harada M, et al. Cancer Res. 2001 Feb 1;61(3):1089-94. Cancer Res. 2001. PMID: 11221837 - T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A. Sensi M, et al. J Exp Med. 1993 Oct 1;178(4):1231-46. doi: 10.1084/jem.178.4.1231. J Exp Med. 1993. PMID: 8376931 Free PMC article. - Recognition of shared melanoma antigens by human tumor-infiltrating lymphocytes.
Topalian SL, Hom SS, Kawakami Y, Mancini M, Schwartzentruber DJ, Zakut R, Rosenberg SA. Topalian SL, et al. J Immunother (1991). 1992 Oct;12(3):203-6. doi: 10.1097/00002371-199210000-00013. J Immunother (1991). 1992. PMID: 1445813 Review. - Immunobiology of human melanoma antigens MART-1 and gp100 and their use for immuno-gene therapy.
Kawakami Y, Rosenberg SA. Kawakami Y, et al. Int Rev Immunol. 1997;14(2-3):173-92. doi: 10.3109/08830189709116851. Int Rev Immunol. 1997. PMID: 9131386 Review.
Cited by
- Machine learning for the identification of neoantigen-reactive CD8 + T cells in gastrointestinal cancer using single-cell sequencing.
Sun H, Han X, Du Z, Chen G, Guo T, Xie F, Gu W, Shi Z. Sun H, et al. Br J Cancer. 2024 Jul;131(2):387-402. doi: 10.1038/s41416-024-02737-0. Epub 2024 Jun 7. Br J Cancer. 2024. PMID: 38849478 - Loss of p14 diminishes immunogenicity in melanoma via non-canonical Wnt signaling by reducing the peptide surface density.
Wohlfarth J, Kosnopfel C, Faber D, Berthold M, Siedel C, Bernhardt M, Schlosser A, Aprati T, Liu D, Schrama D, Houben R, Schadendorf D, Goebeler M, Meierjohann S, Schilling B. Wohlfarth J, et al. Mol Oncol. 2024 Oct;18(10):2449-2470. doi: 10.1002/1878-0261.13660. Epub 2024 May 28. Mol Oncol. 2024. PMID: 38807304 Free PMC article. - Gene network-based and ensemble modeling-based selection of tumor-associated antigens with a predicted low risk of tissue damage for targeted immunotherapy.
Lischer C, Eberhardt M, Flamann C, Berges J, Güse E, Wessely A, Weich A, Retzlaff J, Dörrie J, Schaft N, Wiesinger M, März J, Schuler-Thurner B, Knorr H, Gupta S, Singh KP, Schuler G, Heppt MV, Koch EAT, van Kleef ND, Freen-van Heeren JJ, Turksma AW, Wolkenhauer O, Hohberger B, Berking C, Bruns H, Vera J. Lischer C, et al. J Immunother Cancer. 2024 May 9;12(5):e008104. doi: 10.1136/jitc-2023-008104. J Immunother Cancer. 2024. PMID: 38724462 Free PMC article. - Evaluating deep learning-based melanoma classification using immunohistochemistry and routine histology: A three center study.
Wies C, Schneider L, Haggenmüller S, Bucher TC, Hobelsberger S, Heppt MV, Ferrara G, Krieghoff-Henning EI, Brinker TJ. Wies C, et al. PLoS One. 2024 Jan 19;19(1):e0297146. doi: 10.1371/journal.pone.0297146. eCollection 2024. PLoS One. 2024. PMID: 38241314 Free PMC article.
References
- J Am Acad Dermatol. 1983 Nov;9(5):689-96 - PubMed
- J Immunother Emphasis Tumor Immunol. 1993 Aug;14(2):88-93 - PubMed
- Science. 1986 Sep 19;233(4770):1318-21 - PubMed
- J Immunol. 1987 Feb 1;138(3):989-95 - PubMed
- Proc Natl Acad Sci U S A. 1987 May;84(10):3365-9 - PubMed
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases
Research Materials